Characteristics of the study populationa
| All Patients (n = 154) | |
|---|---|
| Basic demographics and risk factors, No. (%) | |
| Age (mean) | 64.5 (SD, 14.7) |
| Male | 74 (48.1) |
| Hypertension | 70 (45.5) |
| Diabetes | 43 (27.9) |
| Dyslipidemia | 13 (8.4) |
| Smoking | 53 (34.4) |
| Coronary artery occlusive disease | 19 (12.3) |
| History of previous stroke | 17 (11.0) |
| Atrial fibrillation | 13 (8.4) |
| Clinical conditions | |
| Lesion side | |
| Right | 70 (45.5) |
| Left | 84 (54.5) |
| Lesion location | |
| MCA | 125 (81.2) |
| ICA, petrocavernous | 29 (19.8) |
| Initial NIHSS score (median) (IQR) | 14.0 (8.0–19.0) |
| ASPECTS (median) (IQR) | 8.0 (7.0–9.0) |
| IV tPA treatment | 43 (27.9) |
| Endovascular treatment | |
| Technique of the first-line thrombectomy | |
| Stent retriever | 105 (64.9) |
| Contact aspiration | 34 (22.1) |
| Combination of both | 15 (9.7) |
| Concomitant balloon angioplasty | 28 (18.2) |
| Associated antiplatelet medication | |
| Intraprocedural IA glycoprotein IIb/IIIa inhibitor infusion | 103 (66.9) |
| Postprocedural antiplatelets | 76 (97.4) |
| IV glycoprotein IIb/IIIa inhibitor maintenance | 66 (42.9) |
| Oral dual antiplatelets | 131 (85.0) |
↵a Data are presented as No. (%), mean (SD), or median (IQR).